regulation of THP expression in the early AKI does not depend on TNFα. We propose that TNFα regulates THP expression in a homeostatic setting, but the impact of TNFα on THP during kidney injury is superseded by other factors that could inhibit HNF1β-mediated expression of THP.
Introduction
Tamm-Horsfall Protein (THP) is one of the most abundant urinary proteins, expressed and produced exclusively by cells of the thick ascending limbs (TAL) of Henle [1, 2] . The last decade has experienced a surge of knowledge linking THP or mutations in THP to many physiological or pathogenic processes in the kidney [1, 2] . We recently showed that THP is protective against acute kidney injury (AKI) using a mouse model of renal ischemia reperfusion injury (IRI) [3] [4] [5] . The presence of THP in vivo was essential to suppress the ensuing inflammatory response after IRI. Interestingly, we and others showed that THP expression is inhibited at the peak of injury [3, 6, 7] , suggesting that early AKI is a state of relative THP deficiency. During recovery, THP expression is significantly increased and this suggests that this glyco-protein is essential to mitigate the propagation of inflammation and restore homeostasis in the kidney after injury [3] . It is important to note that limited data is available on what factors regulate THP expression [1] . In fact, solid data exists only on Hepatocyte nuclear factor 1 beta (HNF1β), which is a major transcription factor that binds upstream DNA elements of the THP gene, and enhances positively its expression [8] .
Tumor Necrosis Factor alpha (TNFα) is an inflammatory cytokine that is induced in AKI and is implicated in the pathogenesis of kidney injury [9] [10] [11] [12] . TNFα itself can lead to cytotoxic effects and to the activation of a proinflammatory cascade [9, 11] . However, TNFα is also endogenously expressed in TAL [13] , and is thought to affect the transport properties of this tubular segment [14] . Since THP may also have a regulatory effect on the function of TAL, it is possible that TNFα could regulate THP expression, especially during kidney injury. Therefore, we hypothesized that TNFα inhibits the expression on THP during the early phase of AKI, thereby contributing to the pathogenesis of this disease. This study was undertaken to test this hypothesis, in the context of understanding the regulation of THP expression in AKI, using an ischemia-reperfusion model of AKI in mice in conjunction with in vitro experiments.
Methods

Animal Surgery
Animal experiments and protocols were approved by the Indiana University Animal Care and Use Committee. 8-10 weeks old mice 129/SvEv (Taconic) were used as previously described [5, 15, 16] . TNFα knockout animals and their congenic C5BL6 strain were from Jackson labs. Ischemia reperfusion surgery using bilateral renal pedicle clamping was as previously described [5, 17] . We used a 22, 30, or 35 min ischemia times to induce varying severity of kidney injury, followed by 6, 24, or 48 h reperfusion based on previous studies [5] . In all TNFα neutralization experiments, we used a 30-minutes clamp time [5] . Because TNFα -/-mice were on C5BL6 background, we used a 35 min clamp time to induce significant injury based on previous studies [17] . Sham surgery consisted of an identical procedure without application of the micro aneurysm clamps. All animals received subcutaneous analgesic (bruprenorphine 0.1 mg/kg) at the end of the surgery and every 12 h for 48 h or until euthanasia. Serum creatinine was measured using capillary electrophoresis [18] , performed at the UT Southwestern O'Brien Center of Excellence.
TNFα neutralization was done using 200 μg of intra-peritoneal injection of TNFα neutralizing antibody (R&D) dissolved in 1 cc PBS compared to IgG or PBS using a previously described method [4] . Two protocols were used where TNFαAb was given 4 h before or at the time of surgery, yielding similar results (data not shown).
Immunofluorescence Confocal Microscopy
Protocols for immunostaining vibratome sections were previously reported [5, 19] . Confocal microscopy was done using an Olympus Fluoview laser scanning confocal microscope as previously described [4, 20] . We used primary antibodies against HNF1β (Sc-22840, H-85, Santa Cruz), THP (AbD Serotec cat#8595-0054), and TNFα (Novus, NBPI-19532).
Western Blot for THP
Western blot was performed as was described previously [3, 19] . Blocking was done using 5% nonfat dry milk. THP was detected using a sheep anti-human THP (1: 500; AbD Serotec cat#8595-0054) primary, and a horseradish peroxidase-labeled rabbit anti-sheep (1: 2,000; Upstate) secondary antibody. Blots were stripped and re-probed for actin using mouse anti-actin (1: 1,000; Millipore (cat#MAB1501) and a goat anti-mouse secondary antibody (1: 50,000). Bands were detected by enhanced chemiluminescence (ECL, Amersham Corp.). Protein extract from THP -/-kidneys [3] were used as negative controls. Band densitometry was performed using ImageJ (NIH) and measurements are reported after normalization to actin.
MKTAL Cell Cultures and TNFα Dose Response Experiments
MKTAL is a thick ascending limb cell line that was isolated and characterized by Bourgeois et al. [21] . Cells are cultured in DFS, which consists of 1: 1 mixture of DME (Gibco #10567-014) and Ham's F12 (Gibco #31765-035) medium containing 5% FBS (Lonza BioWhittaker #14-502F). Experiments were performed when cells were 70-80% confluent. All experiments were performed in triplicates, and representative experiments are shown for each experimental condition. TNFα (R&D Systems #410-MT-010/CF) was added at 1, 10, and 20 ng/ml as indicated. Control wells without TNFα were used for each time point. After 2, 6, or 24 h of incubation, flasks from each group were aspirated, trypsinized, and harvested as above.
Real-Time PCR
RNA extraction from whole kidneys and from MKTAL cells was done using TriReagent (Ambion, AM9738) according to the manufacturer's protocol. Purified RNA was treated with DNAse 1 (AB #AM2222) and subsequently reverse-transcribed using High Capacity cDNA Reverse Transcription Kit (AB #4374966). Real-time PCR was performed on the equivalent of 10 or 20 ng RNA in Applied Biosystems (AB) Step One Plus using TaqMan Gene Expression Assays also from AB (THP: Mm00447649_m1; MCP-1: Mm99999056_m1, TNFα: Mm00443258_m1; HNF1β: Mm00447459_m1). Cycling parameters were: 50 ° C for 2 min, then 95 ° C for 10 min followed by 40 cycles of 95 ° C for 15 s and 60 ° C for 1 min. We verified that the levels of endogenous controls (GAPDH) were not affected by changes in experimental conditions (CT changes <0.5). All expression was normalized to endogenous controls and reported as fold change compared to control using the delta-delta CT method, according to the manufacturer's instructions.
Statistical Analysis
Values of each experimental group are reported as mean ± standard error. A two tailed t test was used to examine the difference in means for continuous data. Statistical significance was determined at the 0.05 significance level.
Results and Discussion
Changes in THP Expression in the Outer Medulla after Ischemia Reperfusion Injury (IRI)
Previous work from our lab and others showed that THP mRNA is significantly downregulated at the peak of kidney injury in rat and mice models [3, 6, 7] . In the current study, we aimed to confirm these previous reports and investigate in more detail the changes in THP protein after severe IRI ( fig. 1 ). Using immuno-fluorescence confocal microscopy, we showed a significant decrease in THP expression 24 h after IRI in TAL ( fig. 1 c,  d ) compared to sham ( fig. 1 a, b) . Furthermore, using western blot on total kidney lysates, we confirmed the decrease in THP protein after injury ( fig. 1 e) . We also performed real-time PCR on total kidney RNAs to measure changes in THP mRNA expression in mice 6 and 24 h after IRI surgery as compared to sham mice. As shown in figure 1 f, THP expression was significantly decreased 24 h after IRI, which correlates with the protein findings in figure 1 d, e. Therefore, both THP message and protein are significantly inhibited 24 h after IRI, which coincides with the peak of injury. These findings are consistent with previous reports [3, 6, 7] , with the added knowledge that the reduction in THP protein, especially in total kidney lysates, is more evident with severe injury ( fig. 1 e) compared to less severe injury as we reported previously [3] . In fact, the level of THP in total kidney lysates depends on the rate of THP production by TAL, the half-life of THP (reported to be rather short: about 9 h in rabbit and 16 h in human; data in mouse not available [2] ), and the successful excretion of urinary THP out of the kidney by the flow of urine. Therefore, it is expected that the oliguria induced by IRI will retain THP in the tubular lumen or bound to urinary casts and attenuate the decrease in THP protein measurements after IRI. However, our current data suggest that the decrease in THP production by TAL that occurs with severe injury is so profound, that it also reduced THP levels in total kidney lysates. Of note that we previously showed that the THP expression rebounds during recovery (starting at 48 h after IRI) and THP levels are significantly increased during that time point [3] .
Hepatocyte Nuclear Factor 1β and THP Expression in Ischemia Reperfusion Injury
It is known that HNF1β, a transcription factor, binds DNA element of the UMOD gene and positively regulates its transcription [8] . Therefore, we hypothesized that the level and nuclear translocation of this transcription factor could serve as a useful surrogate for HNF1β-mediated transactivation of the THP gene. Using confocal immuno-fluorescence microscopy, we found that in sham kidneys, HNF1β was localized to TAL primarily in the cytoplasm ( fig. 2 a-d) . HNF1β staining was significantly decreased at 24 h after ischemia. At 48 h, HNF1β expression was significantly increased and localized to the nuclei of TAL (2I-L) and proximal tubular segments. In figure 2 Panel M, we also measured the changes in HNF expression in total kidneys extracts after IRI (with increasing severity of injury, 22 and 30 min clamp times) compared to sham. Regardless of injury severity, there was an initial increase in HNF1β mRNA level at 6 h after injury, followed by a significant decrease at 24 h, which correlated with the protein level in 2 E-H. A recovery at 48 h was observed for HNF1β mRNA level, which coincided with the increase in protein level at that time point. Although the apparent increase in HNF1β staining at 48 h appears disproportionally elevated compared to the mRNA, this could be due to the nuclear translocation/concentration of HNF1β and/or a post-transcriptional effect. A lower magnification (20× objective) of the changes of HNF1β within the outer medulla is also provided in figure 3 . Taken together, these data show that the level of HNF1β is significantly decreased at the peak of injury, which correlates with the decrease in THP expression, and suggests that the inhibition of THP at the peak of injury may be HNF1β-dependent.
Our study shows that with recovery, HNF1β translocates to the nuclei of TAL, which could explain partly the recovery of THP described previously [3] . However, an interesting finding is that HNF1β nuclear translocation appears to be a generalized phenomenon because it also occurs in proximal tubules. This supports previous findings that HNF1β could be an important factor in the overall recovery of various renal tubular cells from AKI [22, 23] .
Upregulation of TNFα Expression, and Localization to TAL Segments in the Outer Medulla after Ischemia Reperfusion Injury
Tumor Necrosis Factor alpha (TNFα) is an inflammatory cytokine that is induced in AKI and is implicated in the pathogenesis of kidney injury [9] [10] [11] [12] . TNFα itself can lead to cytotoxic effects and to the activation of a proinflammatory cascade [9, 11] . However, TNFα is also endogenously expressed in TAL [13] , and is thought to affect the transport properties of this tubular segment [14] . Since THP may also have a regulatory effect on the function of TAL, it is possible that TNFα could inhibit THP expression at baseline and especially at the peak of AKI. Therefore, we studied TNFα expression in kidney sections from mice after IRI or sham surgeries using immuno-fluorescence confocal microscopy. As shown in figure  4 , TNFα expression started to increase 6 h after IRI, and localized predominantly to TAL and less significantly to S3 segments in the junction area between outer and inner stripes within the outer medulla ( fig. 4 b) . TNFα expression increased even further at 24 h after IRI (4C). Using real-time PCR, we also measured the changes in TNFα expression in total kidney extracts after IRI compared to sham ( fig. 4 d) . In IRI 22 min, TNFα mRNA began to increase 6 h after moderate injury and peaked 24 h after IRI (5.6 ± 1.0 fold increase vs. sham, p < 0.05). At 48 h, TNFα expression decreased, consistent with recovery from AKI. In more severe injury (IRI 30 min), TNFα peak was significantly higher and occurred earlier compared to moderate injury. Taken together, this data shows that TNFα is significantly increased in TAL segments at the peak of injury, which coincides with the inhibition of THP expression.
TNFα as an Inhibitor of THP Expression in TAL Cells
To determine whether TNFα itself caused downregulation of THP expression, we incubated various concentrations of TNFα (1, 10, and 20 ng/ml) with MKTAL cells (an established thick ascending limb cell line [21] ), and studied THP mRNA expression using real-time PCR at various time points after incubation (2, 6 and 24 h). To verify the reactivity of cells to TNFα, we concurrently studied the expression of MCP-1 (Monocyte Chemotactic Protein-1), a macrophage chemo-attractant that can be induced by TNFα [12] . There was no significant change HNF1β expression and nuclear translocation after IRI. Representative confocal immunofluorescent images (60× objective) of outer medulla sections from kidneys after sham ( a -d ) and IRI surgeries (22 min clamp) with 24 or 48 h reperfusion ( e -h and i -l , respectively) immunostained for HNF1β expression (red channel). Oregon green-phalloidin was used to identify S3 segments (green channel), and DAPI stain was used for nuclei (blue channel), with merged images shown on the right column. Thick ascending limbs (TAL) were marked by the letter T. In sham, HNF1β expression was predominantly seen in TAL in a cytoplasmic pattern (arrows in a ). 24 h after IRI, HNF1 expression was decerased. However at 48 h after IRI, there was a widespread upregulation of HNF1β in a nuclear distribution seen not only in TAL, but also in S3 segments. Asterisk in J mark injured S3 segments. Bar graphs in m show changes of HNF1β mRNA after IRI with increasing severity (22 and 30 min clamp times) measured as fold increase compared to sham reference using real-time PCR. * denotes statistical significance compared to sham. . Oregon green-phalloidin was used to identify S3 segments (green channel), and DAPI stain was used for nuclei (blue channel). Thick ascending limbs (TAL). S3 (proximal tubular segments). 5 a) . At 6 h, we detected a significant decrease in THP expression, which was comparable in all concentrations used (0.6-0.65 fold decrease vs. control). At 24 h, we observed recovery of THP expression with the lowest TNFα concentration used (1.04 ± 0.10 fold change vs. control). A partial recovery was seen with the intermediate (e.g., 10 ng/ml) TNFα concentration (0.73 ± 0.02 fold change, p < 0.05). In contrast, no recovery but rather a further decrease was seen with the highest TNFα concentration used (0.40 ± 0.04 fold change, p < 0.05). Conversely, MCP-1 was induced significantly in all the times points. The increase was proportional to the concentration of TNFα used ( fig. 5 b) . Figure 5 c also shows the level of HNF1β mRNA in MKTAL cells treated with TNFα. Although HNF1β levels were slightly increased at 2 h after TNFα treatment, these levels were unaffected by TNFα in all subsequent time points, suggesting that TNFα has no impact of HNF1β levels in TAL cells.
The identification of TNFα as an inhibitor of THP expression in TAL cells is novel finding of this study. These findings could be relevant to understand regulatory processes within TAL, especially in view of data by Ferreri and colleagues, that TNFα is endogenously expressed by TAL [13, 14] . Recently, Mutig et al. showed that THP could play a facilitative role in the proper functioning of NKCC2 [24] . Therefore, THP inhibition by TNFα could alter the function of NKCC2; this also supports the recent findings by Battula et al. that TNFα is an endogenous inhibitor of NKCC2 [14] . We acknowledge that using a transformed cell line such as MKTAL cells has its limitations, especially pertaining to the applicability of the results to primary cells or to an in vivo setting. Therefore, we also investigated THP expression in kidneys from sham TNFα knockout mice, compared to kidneys from the corresponding congenic background strain. Figure 5 d shows a noticeable trend toward increase in THP expression in TNFα -/-compared to TNFα +/+ kidneys (p = 0.08), suggesting that TNFα may be an endogenous inhibitor of THP expression.
The Effect of TNFα Inhibition or Genetic Deletion on THP and HNF1β Expression during Kidney Injury in vivo
To determine the importance of TNFα in regulating THP expression after AKI in vivo, we neutralized TNFα in mice subjected to renal IRI using a specific neutralizing antibody as described in methods. Figure 6 shows that TNFα neutralization did not affect kidney injury, as indicated by serum Cr level (6A), nor did it change the level of THP mRNA (6B) and protein (6C). Similarly, HNF1β expression was not affected by TNFα neutralization (6B). To verify that the lack of an effect was not due to incomplete TNFα neutralization, we studied kidney injury and THP expression in TNFα -/-and TNFα +/+ mice ( fig. 6 d) . Surprisingly, TNFα -/-mice sustained more kidney injury than their wild type controls at 24 h post IRI ( fig. 6 d, left panel) . THP expression was also significantly lower in TNFα -/-( fig. 6 d, right panel) , suggesting that its expression predominantly correlates with the severity of injury. It is important to acknowledge, in interpreting the data, that genetic variability between C57BL6 and 129/SvEv could be a variable in determining the response to injury and THP expression. However, the fact that both THP inhibition in 129/SvEv or genetic deletion in C57BL6 did not increase THP expression after injury strongly supports the conclusions reached.
Taken together, these studies uncover TNFα as an inhibitor of THP expression in TAL cells via an HNF1β-independent pathway. However, it appears that TNFα may not be the major regulator of THP expression after IRI, and that TNFα-independent factors supersede TNFα in regulating THP expression in vivo, possibly via an HNF1β-dependent fashion. Furthermore, our data also highlight the complex role of TNFα in AKI. It appears that the outcome of TNFα inhibition post AKI depends on the type of injury. It is beneficial in septic AKI [9] and in cisplatin nephrotoxicity [12] . However, it is harmful in tunicamycin toxicity [25] , and to our knowledge, this is the first study on TNFα inhibition in mouse IRI. Although TNFα inhibition was protective in rat IRI [11, 26] , our data suggest that inhibition of TNFα may not be acutely beneficial in mouse renal ischemic injury. Interestingly, similar discrepancies for p53 inhibition were found between the rat and mouse ischemic injury [27] , suggesting a difference in the nature of ischemic injury between the two species. The reasons for the variability in the acute actions of TNFα between mouse and rat will need further investigations.
In conclusion, we showed that TNFα can inhibit the expression of THP in TAL via an HNF1β-independent mechanism, but the downregulation of THP expression in the early phases of AKI does not depend on TNFα. We propose that TNFα inhibits THP expression in homeostatic settings, but the impact of TNFα on THP during kidney injury is superseded by other factors that could inhibit HNF1β-mediated expression of THP.
